Damian Collins, the chair of the Culture, Media and Sport select committee, confirmed to Sky Sports that the 2012 Tour de France winner would not be called to give evidence, saying that the inquiry was only concerned with organisations that received public money.
"It is not for the Select Committee to investigate the medical records of an individual athlete."
Wiggins has been under scrutiny for a number of months over his use of therapeutic use exemptions, allowing him to treat medical conditions with otherwise banned drugs, prior to the 2011 and 2012 Tours de France and the 2013 Giro d'Italia, and over the contents of a package delivered to Team Sky at the 2011 Critérium du Dauphiné.
In December Dave Brailsford told the select committee that the package contained Fluimucil, but the UK Anti-Doping chief executive said on Wednesday that there was no paper trail to back up Brailsford's claim.
Thank you for reading 20 articles this month* Join now for unlimited access
Enjoy your first month for just £1 / $1 / €1
*Read 5 free articles per month without a subscription
Join now for unlimited access
Try first month for just £1 / $1 / €1